Overview
Horizon Europe topic for developing monoclonal antibodies to prevent and treat infections caused by the listed epidemic-potential virus families.
Eligibility
South African organisations are eligible for Horizon Europe funding under the participating-country rules. The consortium must also meet the requirements and any restrictions in this topic’s call conditions.
- Official source
- European Commission
- Last checked
- 2026-09-19